Lisa Belfiore

Employment

• Inventia Life Science Product Development Scientist
  2019 - Present
• University of Wollongong Illawarra Health and Medical Research Institute Research Assistant
  2013 - 2015

Education

• University of Wollongong PhD Candidate
  2015 - 2019
• University of Wollongong Bachelor of Medical Biotechnology Advanced (Honours)
  2010 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Increased splenic human CD4 + :CD8 + T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in humanized mice
  Transplant Immunology 2019 DOI: 10.1016/j.trim.2019.02.003
  +Save
• Quantification of ligand density and stoichiometry on the surface of liposomes using single-molecule fluorescence imaging
  Journal of Controlled Release 2018 DOI: 10.1016/j.jconrel.2018.03.022
  +Save
• Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities
  Journal of Controlled Release 2018 DOI: 10.1016/j.jconrel.2018.02.040
  +Save
• The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease
  Clinical and Experimental Immunology 2017 DOI: 10.1111/cei.13005
  +Save
• Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin
  Cell Communication and Signaling 2017 DOI: 10.1186/s12964-017-0164-3
  +Save
• N-alkylated isatins evade P-gp mediated efflux and retain potency in MDR cancer cell lines
  Heliyon 2016 DOI: 10.1016/j.heliyon.2015.e00060
  +Save